#188
PDF
IF 9.40
Refined treatment response criteria for indolent systemic mastocytosis proposed by the ECNM-AIM consortium
Bibliographic Details
- Authors
- Corresponding Author(s) +
- Siebenhaar, F.
- Journal / Publisher
- J. Allergy Clin. Immunol. Pract
- Publication Date
- 2022
- Volume / Edition
- 10
- Pages
- 2015-2024
- Impact Factor
- 9.40
Citation
Pyatilova, P., Akin, C., Alvarez-Twose, I., Arock, M., Bonadonna, P., Brockow, K., Butterfield, J. H., Broesby-Olsen, S., Carter, M. C., Castells, M., George, T. I., Gotlib, J., Greiner, G., Gülen, T., Hartmann, K., Hermine, O., Homy, H., Jawhar, M., Lange, M., Lyons, J. J., Maurer, M., Metcalfe, D. D., Nedoszytko, B., Niedoszytko, M., Orfao, A., Reiter, A., Schwaab, J., Sotlar, K., Sperr, W. R., Triggiani, M., Valent, P., Siebenhaar, F.: Refined treatment response criteria for indolent systemic mastocytosis proposed by the ECNM-AIM consortium. J. Allergy Clin. Immunol. Pract 2022: 10; 2015-2024. IF: 9.40